Mitsubishi Chemical in Final Talks to Sell Pharmaceutical Unit to Bain Capital for $3.2 Billion
Investment firm Bain Capital is in talks to acquire Mitsubishi Tanabe Pharma, a unit of Japan's Mitsubishi Chemical Group, in a potential deal, according to people familiar with the matter.
The two companies are in the final stages of negotiations and the deal could be worth more than 500 billion yen, or about $3.2 billion.
Earlier, Nikkei reported that Mitsubishi Chemical had granted a U.S. investment fund the right of first refusal to acquire its pharmaceutical unit.
Meanwhile, Mitsubishi Chemical said in response to the Nikkei report that it had no announcement to make.
"We are constantly reviewing the ideal mix of all businesses across the group, including pharmaceuticals, and are considering all options, including divestitures, to drive reform," the company said in a statement.
2026-10-14
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Mitsubishi Chemical Exits 105,000-Tonne Taiwan MMA Business as China Capacity Reshapes Asian Market
-
Mitsubishi Chemical to Halt Production of Key Epoxy Resin Grades by 2027
-
Asahi Kasei, Mitsui Chemicals, and Mitsubishi Chemical Agree in Principle to Establish New Joint Venture to Restructure Ethylene Production in Western Japan
-
Mitsubishi Chemical Announces Expansion of Advanced Carbon Fiber Production Capacity in Japan and the United States
-
Mitsubishi Chemical Exits the Manufacturing of Polyester Resins for Printer Toners
-
Mitsubishi Chemical Invests in Australia’s Licella Holdings
-
ENEOS and Mitsubishi Chemical Complete Chemical Recycling Facility at Ibaraki Plant
-
Mitsubishi Chemical Nantong PMMA Plant to Relocate
-
Gelest, a Mitsubishi Chemical Group Company, Invests in Specialty Materials Production Facility in the United States
-
Mitsubishi Chemical Expands Flame-Retardant Compound Capacity in China and France
Recommend Reading
-
A Rare Vote of Confidence: INEOS to Invest €250 Million in French Cracker Plant
-
Betting on Next-Generation Metabolic Therapies: Pfizer’s Big Wager on Metsera and Its Strategic Reshaping in China
-
BASF Plans IPO for Agricultural Solutions Business
-
LANXESS Expands Rubber Additives Production at Qingdao Plant
-
BASF Partners with Andritz for Carbon Capture Project in Aarhus
-
MTBE market trend continues to rise
-
This Week's Styrene Market Fluctuates within a Range (11.17-11.21)
-
Business Society September 30, 2026 Acrylonitrile Trend Analysis: Weak Rebound
-
This week, the price of 180CST fuel oil in China continued to rise
-
This Week, Caustic Soda Prices Remain Stable (11.17-11.21)
- Hot Searches
- sulphuric acid price
- purchase ammonium nitrate
- pp polypropylene resin price asia 2025 english
- buy cerebrolysin
- price of ammonium nitrate fertilizer
- white mineral oil
- dipotassium phosphate for food market
- itpp for sale
- r3ta peptide buy
- phosphorus pentoxide sds
- fluocinolone oil ear drops
- price of base oil